Long-term dosing of AMG 531 is effective and well tolerated in thrombocytopenic patients with immune thrombocytopenic purpura.

被引:10
作者
Bussel, JB
Kuter, DJ
George, JN
Aledort, LM
Lichtin, AE
Lyons, RM
Nieva, J
Wasser, JS
Bourgeois, E
Kappers-Klunne, M
LeFrere, F
Schipperus, MR
Kelly, R
Christal, J
Chen, CF
Nichol, JL
机构
[1] Cornell Med Ctr, New York, NY USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[4] Mt Sinai Hosp, New York, NY 10029 USA
[5] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[6] Hematol Oncol Assoc So Tex, San Antonio, TX USA
[7] Scripps Clin, La Jolla, CA USA
[8] DeQuattro, Community Canc Ctr, Manchester, CT USA
[9] CHRU Claude Huriet, Lille, France
[10] Erasmus MC, Rotterdam, Netherlands
[11] Hop Necker Enfants Malad, Paris, France
[12] HagaZiekenhuis, The Hague, Netherlands
[13] Amgen Inc, Global Dev, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1182/blood.V106.11.220.220
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
220
引用
收藏
页码:68A / 68A
页数:1
相关论文
empty
未找到相关数据